Pharmacokinetic study on the mechanism of interaction of sulfacetamide sodium with bovine serum albumin: A spectroscopic method

Biopharmaceutics and Drug Disposition

Volumn 31, Issue 2-3, 2010, Pages 120-128

  Naik, Praveen N ^a   Chimatadar, Shivamurti A ^a   Nandibewoor, Sharanappa T ^a  

^a KARNATAK UNIVERSITY   (India)

Author keywords

Bovine serum albumin binding studies; Fluorescence resonance energy transfer; Spectral studies; Sulfacetamide sodium

Indexed keywords

ALGINIC ACID; BOVINE SERUM ALBUMIN; COBALT; GUAR GUM; HYDROXYETHYLCELLULOSE; MAGNESIUM ION; METHYLCELLULOSE; NICKEL; POLYVINYL ALCOHOL; POTASSIUM ION; SULFACETAMIDE; VANADIUM;

ARTICLE; BINDING KINETICS; CONFORMATIONAL TRANSITION; DRUG PROTEIN BINDING; FLUORESCENCE SPECTROSCOPY; HYDROGEN BOND; INFRARED SPECTROSCOPY; PROTEIN STRUCTURE; THERMODYNAMICS; ULTRAVIOLET SPECTROSCOPY;

ANIMALS; ANTI-BACTERIAL AGENTS; CATTLE; DRUG INTERACTIONS; SERUM ALBUMIN, BOVINE; SULFACETAMIDE;

EID: 77951040020     PISSN: 01422782     EISSN: 1099081X     Source Type: Journal    
DOI: 10.1002/bdd.696     Document Type: Article

References (35)

1. Hu YJ, Liu Y, Shen XS, Fang XY, Qu SS. Studies on the interaction between 1-hexylcarbamoyl-5-fluorouracil and bovine serum albumin. J Mol Struct 2005; 738: 143-147. (Pubitemid 40326171)
2. Kamat BP. Study of the interaction between fluoroquinolones and bovine serum albumin. J Pharm Biomed Anal 2005; 39: 1046-1050. (Pubitemid 41441736)
3. Kamat BP. Spectroscopic investigations on the interaction of bovine serum albumine with amoxicillin and cloxacillin. J Photosci 2005; 12: 11-15.
4. Kamat BP, Seetharamappa J. In vitro study on the interaction of mechanism of tricyclic compounds with bovine serum albumin. J Chem Sci 2005; 117: 649-655.
5. Cater DC, Ho JX. Structure and ligand binding properties of human serum albumin. Adv Protein Chem 1994; 45: 153-203.
6. Olson RE, Christ DD. Plasma protein binding of drugs. Ann Rep Med Chem 1996; 31: 327-337.
7. He XM, Carter DC. Atomic structure and chemistry of human serum albumin. Nature 1992; 358: 209-215.
8. Guo M, Zou JW, Yi PG, Shang ZC, Hu GX, Yu QS. Binding interaction of gatifloxacin with bovine serum albumin. Anal Sci 2004; 20: 465-470.
9. Halling-Sørensen B, Nors Nielsen S, Lanzky PF, Ingerslev F, Holten Lützhoft HC, Jørgensen SE. Occurrence, fate and effects of pharmaceutical substances in the environment - A review. Chemosphere 1998; 36: 357-393.
10. Kümmerer K. Drugs in the environment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources-a review. Chemosphere 2001; 45: 957-969. (Pubitemid 32947761)
11. Heberer T. Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol Lett 2002; 131: 5-17. (Pubitemid 34461906)
12. Carballa M, Omil F, Lema JM et al. Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. Water Res 2004; 38: 2918-2926. (Pubitemid 38829583)
13. Kolpin DW, Furlong ET, Meyer MT, et al. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: A national reconnaissance. Environ Sci Technol 2002; 36: 1202-1211.
14. Daughton CF, Ternes TA. Pharmaceuticals and personal care products in the environment: agents of subtle change? Environ Health Perspect 1999; 107(Suppl. 6): 907-938.
15. Holm JV, Ruegge K, Bjerg PL, Christensen TH. Occurrence and distribution of pharmaceutical organic compounds in the groundwater down-gradient of a landfill (Grindsted, Denmark). Environ Sci Technol 1995; 29: 1415-1420. (Pubitemid 26437848)
16. Hirsch R, Ternes T, Haberer K, Kratz KL. Occurrence of antibiotics in the aquatic environment. Sci Total Environ 1999; 225: 109-118.
17. Ternes TA. Occurrence of drugs in German sewage treatment plants and rivers. Water Res 1998; 32: 3245-3260.
18. Battaglin WA, Furlong ET, Burkhardt MR, Peter CJ. Occurrence of sulfonylurea, sulfonamide, imidazolinone, and other herbicides in rivers, reservoirs and ground water in the Midwestern United States, 1998. Sci Total Environ 2000; 248: 123-133.
19. Jones OAH, Voulvoulis N, Lester JN. Human pharmaceuticals in the aquatic environment a review. Environ Technol 2001; 22: 1383-1394. (Pubitemid 34083225)
20. Lakowicz JR. Principles of Fluorescence Spectroscopy, 2nd edn. Plenum Press: New York, 1999; 237.
21. Chen GZ, Huang XZ, Xu JG, Zheng ZZ, Wang ZB. The Methods of Fluorescence Analysis, 2nd edn. Science Press: Beijing, 1990; 2-39.
22. Hu YJ, Yiu L, Wang JB, Xiao XH, Qu SS. Study of the interaction between monoammonium glycyrrhizinate and bovine serum albumin. J Pharm Biomed Anal 2004; 36: 915-919. (Pubitemid 39469437)
23. Cui FL, Fan J, Li JP, Hu Z. Interactions between 1-benzoyl-4-p- chlorophenyl thiosemicarbazide and serum albumin: investigation by fluorescence spectroscopy. Bioorg Med Chem 2004; 12: 151-157. (Pubitemid 38096227)
24. Cui FL, Fan J, Ma DL, Liu MC, Chen XG, Hu Z. A study of the interaction between a new reagent and serum albumin by fluorescence spectroscopy. Anal Lett 2003; 36: 2151-2166. (Pubitemid 37048201)
25. Shuyun B, Daqian S, Yuan T, Xin Z, Zhongying L, Hanqi Z. Molecular spectroscopic study on the interaction of tetracyclines with serum albumins. Spectrochim Acta Part A 2005; 61: 629-636. (Pubitemid 40072640)
26. Sulkowska A. Interaction of drugs with bovine and human serum albumin. J Mol Struct 2002; 614: 227-232. (Pubitemid 34987732)
27. Lakowicz JR, Weber G. Quenching of fluorescence by oxygen. Probe for structural fluctuations in macromolecules. Biochemistry 1973; 12: 4161-4170.
28. Deepa S, Mishra AK. Fluorescence spectroscopic study of serum albumin- bromadiolone interaction: fluorimetric determination of bromadiolone. J Pharm Biomed Anal 2005; 38: 556-563. (Pubitemid 40733196)
29. Ying L, Wenying H, Jiaqin L, Fenling S, Hu Z, Xingguo C. Binding of bioactive component jatrorrhizine to human serum albumin. Biochim Biophys Acta 2005; 1722: 15-21. (Pubitemid 40222400)
30. Ross DP, Subramanian S. Thermodynamics of protein association reactions: Forces contributing to stability. Biochemistry 1981; 20: 3096-3102.
31. Förster T, Sinanoglu O. (eds). Modern Quantum Chemistry, vol. 3. Academic Press: New York, 1996; 93.
32. Valeur B, Brochon JC. New Trends in Fluorescence Spectroscopy, 6th edn. Springer Press: Berlin, 1999; 25.
33. Ying YC, Hou AX, Yi L, Hui T, Qu SS. Some properties of the interaction between 2,2-diselanadibenzoic acid and serum albumin. J Pharm Biomed Anal 2005; 39: 263-267. (Pubitemid 41114863)
34. Witold KS, Henry HM, Dennis C. Determination of protein secondary structure by Fourier transform infrared spectroscopy: A critical assessment. Biochemistry 1993; 32: 389-394. (Pubitemid 23034873)
35. He W, Li Y, Xuen C, Hu Z, Chen X, Sheng F. Effect of Chinese medicine alpinetin on the structure of human serum albumin. Bioorg Med Chem 2005; 13: 1837-1845. (Pubitemid 40215271)